— Know what they know.
Not Investment Advice

ETER OTC

Enterra Corporation
1W: +0.0% 1M: +3.3% 3M: +3.3% YTD: -18.4% 1Y: -43.6% 3Y: -69.0% 5Y: +210.0%
$0.03
+0.00 (+0.00%)
 
OTC · Technology · Information Technology Services · Tech Score Neutral · Power 50 · $3.3M mcap · 37M float · 0.0003% daily turnover · Short 71% of daily vol

Balance Sheet Trends

Total Assets
$940K -3.6% ▼
5Y CAGR: +92.6%
Total Liabilities
$473K +8.8% ▲
5Y CAGR: +22.6%
Shareholders Equity
$467K -13.6% ▼
Cash & Investments
$6K +355.6% ▲
5Y CAGR: -29.8%
Total Debt
$277K +3.2% ▲
5Y CAGR: +114.6%
Net Debt
$271K +1.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$11K$16K$3K$1K$6K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$11K$16K$3K$1K$6K
Net Receivables$0$3K$12K$18K$16K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$11K$19K$15K$20K$22K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$1M$1M$955K$918K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$37K$0$0
Total Non-Current Assets$0$1M$1M$955K$918K
Total Assets$11K$1M$1M$975K$940K
— Liabilities —
Accounts Payable$0$102K$64K$166K$196K
Short-Term Debt$0$6K$6K$269K$277K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$239K$193K$254K$0$0
Total Current Liabilities$239K$301K$324K$435K$473K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$239K$301K$324K$435K$473K
— Equity —
Common Stock$95K$107K$107K$107K$107K
Retained Earnings-$33M-$33M-$33M-$34M-$34M
Accumulated OCI-$95K-$107K-$107K$0$0
Total Stockholders Equity-$229K$823K$759K$541K$467K
Total Liabilities & Equity$11K$1M$1M$975K$940K
— Key Metrics —
Total Debt$0$6K$6K$269K$277K
Net Debt-$11K-$10K$3K$267K$271K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms